Evidence map›Paper›PMID 39050946›Full record

ArticleNanoscale advances2024

A novel nanocomposite drug delivery system for SARS-CoV-2 infections.

Uday Chintapula, Shazeed-Ul Karim, Priyanka Raghunathan Iyer, Haritha Asokan-Sheeja, Biswas Neupane, Farzana Nazneen, He Dong, Fengwei Bai, Kytai T Nguyen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Uday ChintapulaDepartment of Bioengineering, University of Texas at Arlington Arlington TX 76010 USA knguyen@uta.edu.
Shazeed-Ul KarimDepartment of Cell and Molecular Biology, University of Southern Mississippi Hattiesburg MS 39406 USA fengwei.bai@usm.edu.
Priyanka Raghunathan IyerDepartment of Bioengineering, University of Texas at Arlington Arlington TX 76010 USA knguyen@uta.edu.
Haritha Asokan-SheejaDepartment of Chemistry and Biochemistry, University of Texas at Arlington Arlington TX 76010 USA.
Biswas NeupaneDepartment of Cell and Molecular Biology, University of Southern Mississippi Hattiesburg MS 39406 USA fengwei.bai@usm.edu.
Farzana NazneenDepartment of Cell and Molecular Biology, University of Southern Mississippi Hattiesburg MS 39406 USA fengwei.bai@usm.edu.ORCID https://orcid.org/0000-0002-8142-7342
He DongDepartment of Chemistry and Biochemistry, University of Texas at Arlington Arlington TX 76010 USA.ORCID https://orcid.org/0000-0002-8494-0475
Fengwei BaiDepartment of Cell and Molecular Biology, University of Southern Mississippi Hattiesburg MS 39406 USA fengwei.bai@usm.edu.
Kytai T NguyenDepartment of Bioengineering, University of Texas at Arlington Arlington TX 76010 USA knguyen@uta.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To develop an inhalable drug delivery system, we synthesized poly (lactic-

Identifiers

PMID39050946
PMCPMC11265598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.